Your browser doesn't support javascript.
loading
CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies.
Hwang, Justin H; Arafeh, Rand; Seo, Ji-Heui; Baca, Sylvan C; Ludwig, Megan; Arnoff, Taylor E; Sawyer, Lydia; Richter, Camden; Tape, Sydney; Bergom, Hannah E; McSweeney, Sean; Rennhack, Jonathan P; Klingenberg, Sarah A; Cheung, Alexander T M; Kwon, Jason; So, Jonathan; Kregel, Steven; Van Allen, Eliezer M; Drake, Justin M; Freedman, Matthew L; Hahn, William C.
Affiliation
  • Hwang JH; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, United States.
  • Arafeh R; Department of Medicine, University of Minnesota, Minneapolis, United States.
  • Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • Baca SC; Broad Institute of MIT and Harvard, Cambridge, Cambridge, United States.
  • Ludwig M; Harvard Medical School, Boston, United States.
  • Arnoff TE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • Sawyer L; Broad Institute of MIT and Harvard, Cambridge, Cambridge, United States.
  • Richter C; Harvard Medical School, Boston, United States.
  • Tape S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • Bergom HE; Broad Institute of MIT and Harvard, Cambridge, Cambridge, United States.
  • McSweeney S; Harvard Medical School, Boston, United States.
  • Rennhack JP; Department of Pharmacology, University of Minnesota-Twin Cities, Minneapolis, United States.
  • Klingenberg SA; Warren Alpert Medical School of Brown University, Providence, United States.
  • Cheung ATM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • Kwon J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • So J; Broad Institute of MIT and Harvard, Cambridge, Cambridge, United States.
  • Kregel S; Harvard Medical School, Boston, United States.
  • Van Allen EM; Department of Medicine, University of Minnesota, Minneapolis, United States.
  • Drake JM; Department of Medicine, University of Minnesota, Minneapolis, United States.
  • Freedman ML; Department of Medicine, University of Minnesota, Minneapolis, United States.
  • Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
Elife ; 112022 05 12.
Article in En | MEDLINE | ID: mdl-35550030
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Androgen / Prostatic Neoplasms, Castration-Resistant Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Elife Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Androgen / Prostatic Neoplasms, Castration-Resistant Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Elife Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom